"Calcium Channel Blockers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of drugs that act by selective inhibition of calcium influx through cellular membranes.
| Descriptor ID |
D002121
|
| MeSH Number(s) |
D27.505.519.562.249 D27.505.954.411.192
|
| Concept/Terms |
Calcium Channel Blockers- Calcium Channel Blockers
- Blockers, Calcium Channel
- Channel Blockers, Calcium
- Calcium Channel Antagonists
- Antagonists, Calcium Channel
- Calcium Channel Blocking Drugs
Calcium Antagonists, Exogenous- Calcium Antagonists, Exogenous
- Antagonists, Exogenous Calcium
- Exogenous Calcium Inhibitors
- Exogenous Calcium Antagonists
- Exogenous Calcium Blockaders
- Calcium Blockaders, Exogenous
- Calcium Inhibitors, Exogenous
|
Below are MeSH descriptors whose meaning is more general than "Calcium Channel Blockers".
Below are MeSH descriptors whose meaning is more specific than "Calcium Channel Blockers".
This graph shows the total number of publications written about "Calcium Channel Blockers" by people in this website by year, and whether "Calcium Channel Blockers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 2 | 3 | 5 |
| 1996 | 6 | 3 | 9 |
| 1997 | 7 | 4 | 11 |
| 1998 | 3 | 8 | 11 |
| 1999 | 4 | 2 | 6 |
| 2000 | 3 | 6 | 9 |
| 2001 | 2 | 4 | 6 |
| 2002 | 2 | 2 | 4 |
| 2003 | 2 | 10 | 12 |
| 2004 | 4 | 7 | 11 |
| 2005 | 2 | 5 | 7 |
| 2006 | 3 | 4 | 7 |
| 2007 | 2 | 4 | 6 |
| 2008 | 2 | 6 | 8 |
| 2009 | 1 | 3 | 4 |
| 2010 | 3 | 5 | 8 |
| 2011 | 2 | 5 | 7 |
| 2012 | 0 | 2 | 2 |
| 2013 | 5 | 0 | 5 |
| 2014 | 1 | 3 | 4 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 4 | 4 |
| 2018 | 1 | 3 | 4 |
| 2019 | 0 | 1 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Calcium Channel Blockers" by people in Profiles.
-
A pilot pharmacogenetic study of calcium channel blocker treatment of bipolar mania. Psychiatry Res. 2023 08; 326:115281.
-
Effect of Antihypertensives by Class on Cerebral Small Vessel Disease: A Post Hoc Analysis of SPRINT-MIND. Stroke. 2022 08; 53(8):2435-2440.
-
Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach. J Hypertens. 2022 03 01; 40(3):462-469.
-
Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant Hypertension. Am J Hypertens. 2021 05 22; 34(5):531-539.
-
Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers. Am J Nephrol. 2021; 52(3):250-260.
-
The future of pharmacogenetics in the treatment of hypertension. Pharmacogenomics. 2019 02; 20(3):129-132.
-
Increasing SBP variability is associated with an increased risk of developing incident diabetic foot ulcers. J Hypertens. 2018 11; 36(11):2177-2184.
-
Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment. J Hypertens. 2018 04; 36(4):720-733.
-
Hypertension. Nat Rev Dis Primers. 2018 03 22; 4:18014.
-
Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients. J Am Heart Assoc. 2018 01 04; 7(1).